☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Priority
AstraZeneca's Farxiga (dapagliflozin) Receives the US FDA's Priority Review for Chronic Kidney Disease
January 6, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.